Cargando…
Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
Autores principales: | Mpendo, J, Bayingana, R, Nanvubya, A, Karita, E, Ssetaala, A, Kiwanuka, N, Lehrman, J, Schmidt, C, Hannaman, D, Allen, S, Fast, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441912/ http://dx.doi.org/10.1186/1742-4690-9-S2-P126 |
Ejemplares similares
-
Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
por: Bayingana, R, et al.
Publicado: (2012) -
Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial
por: Mpendo, Juliet, et al.
Publicado: (2020) -
Are fishing communities another most-at-risk-population? Results of a community-based study along Lake Victoria, Uganda
por: Ssetaala, A, et al.
Publicado: (2012) -
Alcohol and illicit drug use among potential HIV vaccine efficacy trial volunteers along Lake Victoria, Uganda
por: Ssekandi, I, et al.
Publicado: (2012) -
Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda
por: Nanvubya, A, et al.
Publicado: (2012)